Good point.
If we have to call in all surviving patients for final evaluation, most of which have been alive for over 30 months. Then you could draw a conclusion that the treatment has been a success.
We will have to wait for the expert posters here to digest and dissect their interpretation.
Ann: CHF P3 Trial Accrues Sufficient Primary Endpoint Events, page-14
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.068(5.38%) |
Mkt cap ! $1.367B | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.23 | $1.18 | $5.354M | 4.463M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 102816 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 62527 | 33 |
View Market Depth
| Last trade - 13.27pm 25/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |